IMUX logo

Immunic (IMUX) Company Overview

Profile

Full Name:

Immunic, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 17, 2014

Indexes:

Not included

Description:

IMUX, a part of Immunic, focuses on developing innovative therapies for autoimmune diseases. The company aims to improve patient outcomes by creating effective treatments that target the immune system, helping those with conditions like multiple sclerosis and inflammatory bowel disease. Their research emphasizes safety and efficacy.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Feb 22, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Apr 15, 2019

Analyst ratings

Recent major analysts updates

Feb 21, 25 HC Wainwright & Co.
Buy
Feb 20, 25 D. Boral Capital
Buy
Jan 7, 25 D. Boral Capital
Buy
Nov 25, 24 HC Wainwright & Co.
Buy
Nov 7, 24 EF Hutton
Buy
Oct 22, 24 EF Hutton
Buy
Sep 18, 24 EF Hutton
Buy
Sep 16, 24 EF Hutton
Buy
Aug 27, 24 B. Riley Securities
Buy
Jul 16, 24 Piper Sandler
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Immunic?
  • Does Immunic pay dividends?
  • What sector is Immunic in?
  • What industry is Immunic in?
  • What country is Immunic based in?
  • When did Immunic go public?
  • Is Immunic in the S&P 500?
  • Is Immunic in the NASDAQ 100?
  • Is Immunic in the Dow Jones?
  • When was Immunic's last earnings report?
  • When does Immunic report earnings?
  • Should I buy Immunic stock now?

What is the ticker symbol for Immunic?

The ticker symbol for Immunic is NASDAQ:IMUX

Does Immunic pay dividends?

No, Immunic does not pay dividends

What sector is Immunic in?

Immunic is in the Healthcare sector

What industry is Immunic in?

Immunic is in the Biotechnology industry

What country is Immunic based in?

Immunic is headquartered in United States

When did Immunic go public?

Immunic's initial public offering (IPO) was on April 17, 2014

Is Immunic in the S&P 500?

No, Immunic is not included in the S&P 500 index

Is Immunic in the NASDAQ 100?

No, Immunic is not included in the NASDAQ 100 index

Is Immunic in the Dow Jones?

No, Immunic is not included in the Dow Jones index

When was Immunic's last earnings report?

Immunic's most recent earnings report was on Nov 7, 2024

When does Immunic report earnings?

The next expected earnings date for Immunic is Feb 28, 2025

Should I buy Immunic stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions